These data suggest a possible role of altered primary structure of IRS‐1 in developing the insulin resistance of the metabolic syndrome and type 2 diabetes is rare and does not contribute to the mechanisms of the vast majority of subjects with insulin resistance. The gene discussed is IRS1; the disease is metabolic syndrome.